XIENCE Xpedition Everolimus-Eluting Coronary Stent System

Description: The XIENCE Xpedition is a drug-eluting coronary stent system developed by Abbott to treat patients with coronary artery disease. It features a cobalt chromium stent platform coated with everolimus, an immunosuppressive drug that helps prevent restenosis by inhibiting tissue growth within the stent. The stent is mounted on a balloon-expandable delivery system designed for precise placement and enhanced deliverability, even in complex anatomies.

Key Features:

• Stent Material: L-605 cobalt chromium alloy
• Drug Coating: Everolimus at 100 µg/cm²
• Polymer Coating: Non-erodible polymers including poly n-butyl methacrylate (PBMA) and PVDF-HFP
• Stent Diameters: 2.25 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 4.0 mm
• Stent Lengths: 8 mm, 12 mm, 15 mm, 18 mm, 23 mm, 28 mm, 33 mm, 38 mm
• Delivery System Working Length: 143 cm
• Balloon Rated Burst Pressure (RBP): 18 atm
• Guide Wire Compatibility: Designed for 0.014" guide wires